Tao MH - Search Results

1

Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study.

Brasky TM, Bonner MR, Moysich KB, Ochs-Balcom HM, Marian C, Ambrosone CB, Nie J, Tao MH, Edge SB, Trevisan M, Shields PG, Freudenheim JL. Brasky TM, et al. Among authors: tao mh. Breast Cancer Res Treat. 2011 Feb;126(1):157-65. doi: 10.1007/s10549-010-1082-x. Epub 2010 Jul 30. Breast Cancer Res Treat. 2011. PMID: 20676755 Free PMC article. Clinical Trial.

2

Body mass and DNA promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study.

Tao MH, Marian C, Nie J, Ambrosone C, Krishnan SS, Edge SB, Trevisan M, Shields PG, Freudenheim JL. Tao MH, et al. Am J Clin Nutr. 2011 Sep;94(3):831-8. doi: 10.3945/ajcn.110.009365. Epub 2011 Jul 20. Am J Clin Nutr. 2011. PMID: 21775555 Free PMC article.

3

Promoter methylation of E-cadherin, p16, and RAR-β(2) genes in breast tumors and dietary intake of nutrients important in one-carbon metabolism.

Tao MH, Mason JB, Marian C, McCann SE, Platek ME, Millen A, Ambrosone C, Edge SB, Krishnan SS, Trevisan M, Shields PG, Freudenheim JL. Tao MH, et al. Nutr Cancer. 2011;63(7):1143-50. doi: 10.1080/01635581.2011.605982. Epub 2011 Sep 14. Nutr Cancer. 2011. PMID: 21916701 Free PMC article.

4

Associations of intakes of magnesium and calcium and survival among women with breast cancer: results from Western New York Exposures and Breast Cancer (WEB) Study.

Tao MH, Dai Q, Millen AE, Nie J, Edge SB, Trevisan M, Shields PG, Freudenheim JL. Tao MH, et al. Am J Cancer Res. 2015 Dec 15;6(1):105-13. eCollection 2016. Am J Cancer Res. 2015. PMID: 27073728 Free PMC article.

5

DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study.

Callahan CL, Wang Y, Marian C, Weng DY, Eng KH, Tao MH, Ambrosone CB, Nie J, Trevisan M, Smiraglia D, Edge SB, Shields PG, Freudenheim JL. Callahan CL, et al. Among authors: tao mh. Epigenetics. 2016 Sep;11(9):643-652. doi: 10.1080/15592294.2016.1192735. Epub 2016 May 31. Epigenetics. 2016. PMID: 27245195 Free PMC article.

6

DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study.

Tao MH, Shields PG, Nie J, Millen A, Ambrosone CB, Edge SB, Krishnan SS, Marian C, Xie B, Winston J, Vito D, Trevisan M, Freudenheim JL. Tao MH, et al. Breast Cancer Res Treat. 2009 Apr;114(3):559-68. doi: 10.1007/s10549-008-0028-z. Epub 2008 May 8. Breast Cancer Res Treat. 2009. PMID: 18463976 Free PMC article.

7

DNA promoter methylation in breast tumors: no association with genetic polymorphisms in MTHFR and MTR.

Tao MH, Shields PG, Nie J, Marian C, Ambrosone CB, McCann SE, Platek M, Krishnan SS, Xie B, Edge SB, Winston J, Vito D, Trevisan M, Freudenheim JL. Tao MH, et al. Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):998-1002. doi: 10.1158/1055-9965.EPI-08-0916. Epub 2009 Feb 24. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19240236 Free PMC article.

8

Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study.

Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, Edge SB, Kallakury BV, Marian C, Trevisan M, Shields PG, Freudenheim JL. Brasky TM, et al. Among authors: tao mh. Cancer Causes Control. 2010 Sep;21(9):1503-12. doi: 10.1007/s10552-010-9579-5. Epub 2010 May 25. Cancer Causes Control. 2010. PMID: 20499154 Free PMC article.

9

Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype.

Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, Edge SB, Kallakury BV, Marian C, Goerlitz DS, Trevisan M, Shields PG, Freudenheim JL. Brasky TM, et al. Among authors: tao mh. Cancer Causes Control. 2011 Jul;22(7):965-75. doi: 10.1007/s10552-011-9769-9. Epub 2011 Apr 23. Cancer Causes Control. 2011. PMID: 21516318 Free PMC article.

10

Association of prediagnostic physical activity with survival following breast cancer diagnosis: influence of TP53 mutation status.

Tao MH, Hainaut P, Marian C, Nie J, Ambrosone C, Edge SB, Trevisan M, Dorn J, Shields PG, Freudenheim JL. Tao MH, et al. Cancer Causes Control. 2013 Dec;24(12):2177-86. doi: 10.1007/s10552-013-0294-x. Epub 2013 Sep 26. Cancer Causes Control. 2013. PMID: 24068557 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters